Valuation: PROT DIAG

Market Cap 28Cr 2.84Cr 2.46Cr 2.32Cr 2.1Cr 3.95Cr 271.88Cr 3.98Cr 11Cr 137.93Cr 11Cr 10Cr 438.49Cr P/E 2024
-2.94x
P/E 2025 -4.28x
Enterprise Value 24Cr 2.42Cr 2.1Cr 1.98Cr 1.8Cr 3.37Cr 232.03Cr 3.39Cr 9.11Cr 117.71Cr 9.09Cr 8.89Cr 374.22Cr EV / Sales 2024
2.16x
EV / Sales 2025 4.15x
Free-Float
12.26%
Yield 2024 *
-
Yield 2025 -
1 day+5.02%
1 week+18.19%
Current month+28.78%
1 month+37.23%
3 months+72.93%
6 months+12.20%
Current year+28.49%
1 week 20.25
Extreme 20.25
23
1 month 16.76
Extreme 16.76
23
Current year 12.46
Extreme 12.46
23
1 year 12.46
Extreme 12.46
23.5
3 years 11.7
Extreme 11.7
90.8
5 years 11.7
Extreme 11.7
169.5
10 years 11.7
Extreme 11.7
806
Manager TitleAgeSince
Chief Executive Officer 62 01/07/2020
Director of Finance/CFO 68 -
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Director/Board Member 70 01/01/2020
Director/Board Member 62 -
Director/Board Member 52 01/10/2023
Change 5-day change 1-year change 3-year change Capi.($)
+5.02%+18.19%-2.95%-73.50% 2.72Cr
-2.15%-2.48%+18.24%-33.42% 1.67TCr
+1.03%+9.63%-34.38%+44.74% 175.15Cr
+0.41%-1.83%-28.07%+22.12% 89Cr
-5.60%-20.40%-61.08%-85.44% 81Cr
0.00%-0.27%+63.36%-2.64% 78Cr
+0.19%-5.08%-38.74%-49.50% 64Cr
+1.76%-8.42%-42.32%-52.63% 56Cr
-0.90%-12.45%-44.80%-39.58% 45Cr
-0.25%-0.62%-8.00%-4.73% 40Cr
Average -0.05%-3.65%-17.87%-27.46% 230.38Cr
Weighted average by Cap. -1.63%-3.13%+6.43%-26.69%

Financials

2024 2025
Net sales 3.63Cr 37.2L 32.23L 30.42L 27.59L 51.76L 36Cr 52.14L 1.4Cr 18Cr 1.4Cr 1.37Cr 57Cr 4.22Cr 43.21L 37.44L 35.33L 32.06L 60.13L 41Cr 60.57L 1.63Cr 21Cr 1.62Cr 1.59Cr 67Cr
Net income -2.69Cr -27.58L -23.9L -22.55L -20.46L -38.38L -26Cr -38.66L -1.04Cr -13Cr -1.04Cr -1.01Cr -43Cr -4.97Cr -50.9L -44.1L -41.62L -37.76L -70.83L -49Cr -71.35L -1.92Cr -25Cr -1.91Cr -1.87Cr -79Cr
Net Debt -1.57Cr -16.11L -13.96L -13.17L -11.95L -22.42L -15Cr -22.58L -60.63L -7.83Cr -60.51L -59.18L -25Cr -4.06Cr -41.58L -36.03L -34L -30.85L -57.86L -40Cr -58.28L -1.56Cr -20Cr -1.56Cr -1.53Cr -64Cr
Logo PROT DIAG
Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.
Employees
22
Date Price Change Volume
14/26/14 SEK 23.00 +5.02% 45,472
11/26/11 SEK 21.90 +6.83% 24,716
10/26/10 SEK 20.50 +1.23% 14,838
09/26/09 SEK 20.25 +1.76% 9,874
08/26/08 SEK 19.90 +2.26% 38,318
  1. Stock Market
  2. Stocks
  3. PRLD Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!